Trials / Unknown
UnknownNCT05996302
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)
Comparative Study of 6-minute Walk Distance (6MWD) in Patients With Pulmonary Vascular Diseases Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 2840m vs. at Low Altitude (LA) Sea Level.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To study the effect of relocation from 2840m (Quito) to sea level (Pedernales) in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live \>2500m on 6-minute walk distance (6MWD)
Detailed description
This research in patients with PVD diagnosed with precapillary PH with right heart catheterization and classified to groups 1 and 4 (PAH or CTEPH) who permanently live at HA \>2500 (PVDHA) will have 6-minute walk distance near their living altitude in Quito at 2840m and at sea level in Pedernales the day after the first and the second night after relocation.
Conditions
- Pulmonary Vascular Disease
- Pulmonary Artery Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Relocation to sea level | Relocation to sea level by bus and stay for 2 days |
Timeline
- Start date
- 2023-07-05
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2023-08-18
- Last updated
- 2023-10-03
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05996302. Inclusion in this directory is not an endorsement.